Health In Tech Director Granted $20k in Restricted Stock
Health In Tech, Inc.
Subscribe to track HIT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Health In Tech Director Granted $20k in Restricted Stock
Company: Health In Tech, Inc. (HIT) Form: 4 | Filed: 2025-10-10 Significance: Low
Insider: Howard William D. Title: Director | Relationship: Director
Transaction: • Type: Grant • Shares: 5,730 • Price: $3.49 • Value: $19,997.70 • Owned After: 106,045
Key Insight: A Director received a routine grant of restricted stock valued at approximately $20k as part of the company's equity incentive plan. This is a standard compensation practice.
Market Context: The filing also disclosed a forfeiture of 28,159 shares, making this grant a smaller, subsequent award. The overall event is neutral for the stock.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Health In Tech, Inc. (HIT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A Director of Health In Tech, Inc. was granted 5,730 shares of restricted Class A Common Stock, valued at approximately $20,000, as part of a standard compensation plan. This event is considered routine and has low trading significance.
- Market Impact: The market impact is expected to be neutral. Stock grants are a common form of non-cash compensation for executives and directors and do not reflect an insider's decision to invest personal capital.
Company Information
| Field | Value |
|---|---|
| Company | Health In Tech, Inc. |
| Ticker Symbol | HIT |
| CIK | 0002019505 |
| Industry | Insurance Agents Brokers & Services [6411] |
Insider Information
| Field | Value |
|---|---|
| Name | Howard William D. |
| CIK | 0001993318 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-08 |
| Transaction Code | A (Grant) |
| Security Type | Class A Common Stock |
| Shares Involved | 5,730 |
| Price Per Share | $3.49 |
| Total Value | $19,997.70 |
| Shares Owned After | 106,045 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a grant (Code A), which is a form of compensation, not an open-market purchase. Such events are typically priced into the company's general and administrative expenses and do not provide a strong signal about the company's future prospects. The value of the transaction is minimal.
Volume & Sentiment
- Expected Volume Impact: Negligible. Compensation-related filings rarely drive trading volume.
- Sentiment Indicator: Neutral. This filing does not provide new information that would sway market sentiment in a bullish or bearish direction.
Investment Insights
Positive Market Indicators
- Equity-based compensation aligns the director's interests with those of shareholders.
Risk Factors
- This is not an open-market purchase, meaning the insider did not use their own capital to increase their stake, which would have been a stronger bullish signal.
Key Takeaways
- Routine Compensation: The grant is part of the Health in Tech Equity Incentive Plan, indicating a standard, pre-planned compensation event.
- Low Financial Impact: A transaction value of ~$20k is not material for the company or the insider.
- Context of Forfeiture: This grant occurred shortly after the same insider forfeited 28,159 restricted shares on October 3, 2025. The net result of the period's reported transactions is a decrease in the insider's holdings.
Contextual Analysis
Timing Significance
The grant's timing appears to be part of a regular compensation schedule, as indicated by the vesting terms mentioned in the filing's footnotes.
Transaction Context
Footnote F2 clarifies that these are restricted shares granted under the company's Equity Incentive Plan, with vesting occurring quarterly. This confirms the nature of the transaction as routine compensation. The filing also includes a separate transaction (Code D) for the forfeiture of 28,159 shares, which provides important context to the insider's overall share movement.
Company Context
This analysis is based solely on the information within the Form 4 filing. No recent major company news or developments are inferred from this document alone.
Risk Assessment
Risk Level: Low
Risk Factors
- The event itself carries no direct investment risk. It is a non-event from a trading signal perspective.
Market Considerations
- Investors should interpret this filing as a routine corporate governance and compensation disclosure, not as a trading signal.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-10 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.